23andMe CEO Wojcicki, New Mountain offer to purchase genetic testing company (ME:NASDAQ)February 21, 2025
Market Trends GH Research prices $150M stock offering (NASDAQ:GHRS)By admin8996erT0allFebruary 5, 2025 Clinical-stage biopharmaceutical company GH Research (NASDAQ:GHRS) priced of its previously announced underwritten public offering in the U.S. of 10M ordinary shares at a public…
